005690Pharmicell005690 info
$4.09info2.45%24h
Global rank16025
Market cap$245.62M
Change 7d9.70%
YTD Performance-10.69%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Pharmicell (005690) Stock Overview

    Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to improve the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC, a liver disease drug; Cellgram_ED for treating impotence; Hearticellgram_AMI, a cardiac disease drug; Cellgram_CKD for the treatment of chronic kidney disease; and Cellgram_AKI for the treatment of acute kidney disease. It develops and produces intermediates of raw material medicines, such as nucleosides and mPEGs; and low dielectric constant material, eco-friendly flame retardant, polyol synthesis catalyst, PET catalyst, etc. In addition, the company provides Half-Serum DMEM, as well as clinical development and commercialization services for new drugs. Further, it operates Twelve, a stem cell bank; and develops and sells stem cell culture media cosmetics. The company was formerly known as FcB2welve Co., Ltd and changed its name to Pharmicell Co., Ltd. in September 2011. Pharmicell Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.

    005690 Stock Information

    Symbol
    005690
    Address
    Ssangbong BuildingSeoul, South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.pharmicell.com
    Country
    🇰🇷 South Korea
    Phone Number
    82 2 3496 0114

    Pharmicell (005690) Price Chart

    -
    Value:-

    Pharmicell Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $4.09
    N/A
    Market Cap
    $245.62M
    N/A
    Shares Outstanding
    60.00M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org